SEC Form 4 · accession 0001179110-16-017392
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Rutherford Carter
Officer — EVP Commercial Ops
Period of report
Jan 4, 2016
Accepted (ET)
Jan 6, 2016 · 5:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 4, 2016 | M | 823 | $26.99 | A | 49,606 | D | |
| Common Stock | Jan 4, 2016 | M | 1,177 | $24.905 | A | 50,783 | D | |
| Common Stock | Jan 4, 2016 | S | 2,000 | $99.20 | D | 48,783 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $24.905 | Jan 4, 2016 | M | 1,177 | D | — | Jul 29, 2019 | Common Stock | 1,177 | 38,823 | D |
| Non-Qualified Stock Option (right to buy)F2 | $26.99 | Jan 4, 2016 | M | 823 | D | — | Jul 30, 2018 | Common Stock | 823 | 0 | D |
Explanation of responses
- F1The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- F2The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.